- cafead Apr 18, 2024 at 11:12: AM
via Analysts hadn’t been expecting positive results from the trial of Cerevel’s drug tavapadon, but data showed it helped improve symptom control.
article source
article source
-
Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
- Thread starter cafead
- Start date
<
Similar threads